Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Dec;19(6):649-57.
doi: 10.1016/j.ceb.2007.10.006. Epub 2007 Nov 26.

Life and death decisions by the E2F transcription factors

Affiliations
Review

Life and death decisions by the E2F transcription factors

Phillip J Iaquinta et al. Curr Opin Cell Biol. 2007 Dec.

Abstract

The E2F transcription factors are critical regulators of genes required for appropriate progression through the cell cycle, and in special circumstances they can also promote the expression of another class of genes that function in the apoptotic program. Since E2Fs can initiate both cell proliferation and cell death, it is not surprising that the pro-apoptotic capacity of these proteins is subject to complex regulation. Recent study has expanded our knowledge of the factors influencing E2F-induced apoptosis as well as downstream targets of E2F in this process.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The E2F Family of Transcription Factors
The E2F family is divided into three groups based on their structure and function. All E2Fs contain a homologous DNA-binding domain (red). The “activating E2Fs” E2F1, E2F2, and E2F3a each contain both a nuclear localization signal (NLS, blue) and a transactivation/pocket protein-binding domain (purple). The “repressive E2Fs” lack the N-terminal domain present in the activating E2Fs, and E2F4 and E2F5 accordingly lack NLS sequences. E2F6, E2F7, and E2F8 lack sequences required for transactivation and pocket protein-binding, and therefore are pocket protein-independent repressors of transcription.
Figure 2
Figure 2. Regulation of cell cycle-dependent transcription by the pRB-E2F pathway
E2F target genes are regulated by repression of transcription in G0/G1 phase, followed by activation in G1/S phase. Repressive complexes containing primarily E2F4 and p107/p130 occupy promoters in G0/G1 phase, and association with chromatin remodeling enzymes such as histone deacetylases (HDAC) contributes to transcriptional repression. pRB binds to and inhibits the transcriptional activity of the activating E2Fs 1-3. Upon cell cycle entry, cyclin-CDK complexes such as cyclin D-CDK4 overcome inhibition by CDK inhibitors such as p16INK4a and phosphorylate the pocket proteins. This phosphorylation leads to disruption of the pocket protein-E2F complexes, causing E2F4 to be exported from the nucleus, and activating E2Fs to bind the promoters of cell cycle-regulated target genes and activate their transcription.
Figure 3
Figure 3. Complex regulation of E2F and p53 in the apoptotic response pathway
Many proteins regulate the activity of E2F and p53 in the apoptotic response. In turn, E2F and p53 transcriptionally activate a large number of pro-apoptotic genes. Transcriptional targets of E2F are shown in red; targets of p53 are shown in blue; targets of both E2F and p53 are indicated in purple.

References

    1. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nature Reviews Mol Cell Biol. 2002;3:11–20. - PubMed
    1. Giangrande PH, Zhu W, Schlisio S, Sun X, Mori S, Gaubatz S, Nevins JR. A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription. Genes Dev. 2004;18:2941–2951. - PMC - PubMed
    1. Di Stefano L, Jensen MR, Helin K. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. Embo J. 2003;22:6289–6298. - PMC - PubMed
    1. Stevaux O, Dyson NJ. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol. 2002;14:684–691. - PubMed
    1. Qin XQ, Livingston DM, Kaelin WG, Jr, Adams PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A. 1994;91:10918–10922. - PMC - PubMed

Publication types

Substances